Login to Your Account

Pharma: Other news to note

Monday, April 28, 2014
Janssen-Cilag International NV, of Beerse, Belgium, said the European Commission approved Vokanamet, a fixed-dose therapy combining canagliflozin and immediate-release metformin hydrochloride in a single tablet, for the treatment of adults with type 2 diabetes mellitus to improve glycemic control.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription